Soon‐Beom Kang

ORCID: 0000-0003-3237-9273
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Cancer-related molecular mechanisms research
  • Gastric Cancer Management and Outcomes
  • Intraperitoneal and Appendiceal Malignancies
  • Colorectal and Anal Carcinomas
  • Gynecological conditions and treatments
  • Viral-associated cancers and disorders
  • Cancer-related Molecular Pathways
  • Estrogen and related hormone effects
  • Management of metastatic bone disease
  • Radiomics and Machine Learning in Medical Imaging
  • Inflammatory mediators and NSAID effects
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Treatments and Studies
  • Molecular Biology Techniques and Applications
  • Reproductive System and Pregnancy
  • DNA Repair Mechanisms
  • Sarcoma Diagnosis and Treatment
  • Urinary and Genital Oncology Studies
  • Body Contouring and Surgery
  • Cancer Risks and Factors

Konkuk University
2014-2019

Seoul National University
2003-2012

New Generation University College
2008-2011

National University College
2011

Seoul National University Hospital
2003-2010

Weatherford College
2009

Seoul National University Bundang Hospital
2008

Chonnam National University
2007

Chonnam National University Hwasun Hospital
2007

Sungkyunkwan University
2007

To estimate the effects of vaginal pH-balanced gel on symptoms and atrophy in breast cancer survivors treated with chemotherapy or endocrine therapy.This was a randomized, double-blind, placebo-controlled study. Breast who experienced menopause after therapy were voluntarily enrolled randomly administered topical placebo three times per week for 12 weeks. Vaginal dryness dyspareunia measured by visual analog scale, health index, pH. The endometrium ovary evaluated transvaginal...

10.1097/aog.0b013e3182118790 article EN Obstetrics and Gynecology 2011-03-23

ERCC1 is a DNA repair gene and has been associated with resistance to damaging agents. In this study we hypothesized that polymorphism of Asn118Asn (C→T) might affect the platinum-resistance epithelial ovarian cancer patients platinum-taxane chemotherapy administered postoperatively. Using SNapShot assay, assessed in 60 patients. Platinum-resistance was defined as progression on platinum-based or recurrence within 6 months completing therapy. Although not significant, less frequently...

10.1038/emm.2006.38 article EN cc-by Experimental & Molecular Medicine 2006-06-01

<i>Background:</i> The aim of this study was to compare the efficacy, safety and achievement target hemoglobin level (Hb ≥10 g/dl) in patients with preoperative anemia due menorrhagia who received intravenous iron sucrose compared oral protein succinylate for management. <i>Methods:</i> Seventy-six Hb levels <9.0 g/dl were scheduled undergo surgical treatment randomized receive either (based on calculated total deficit divided into 2 ampoule infusions intravenously...

10.1159/000210062 article EN Acta Haematologica 2009-01-01

Objective: To evaluate the efficacy of combined oral medroxyprogesterone acetate (MPA)/ levonorgestrel-intrauterine system (LNG-IUS) treatment and to compare diagnostic accuracy endometrial aspiration biopsy with dilatation & curettage (D&C) in young women early-stage cancer (EC) who wished preserve their fertility.Methods: A prospective phase II multicenter study was conducted from January 2012 2017.Patients grade 1 endometrioid adenocarcinoma confined endometrium were treated MPA (500...

10.3802/jgo.2019.30.e47 article EN cc-by-nc Journal of Gynecologic Oncology 2019-01-01

The purpose of this study is to review FIGO stage IB2 cervical cancers in Korea for the past 10 years, and evaluate most frequently employed appropriate management strategy, also assess survival benefits neoadjuvant chemotherapy (NAC). This a retrospective chart 727 patients from 1995 2005. Six hundred ninety-two were enrolled, all dates on which died double checked through “National Registry Death Statistics” National Statistical Office. Management strategies divided into five groups...

10.1111/j.1525-1438.2007.00803.x article EN cc-by-nc-nd International Journal of Gynecological Cancer 2007-01-01

<i>Background:</i> To investigate the feasibility of preoperative integrated positron emission tomography-computed tomography (PET-CT) with fluoro-2-deoxy-<i>D</i>-glucose (FDG) in primary pelvic lymph node (LN) staging before radical hysterectomy (RH) and lymphadenectomy (PLND) cervical cancer. <i>Methods:</i> We reviewed medical records all patients FIGO stage IA2-IIB cancer who underwent a FDG PET-CT type II or III RH PLND between January 1, 2003, July...

10.1159/000162101 article EN Gynecologic and Obstetric Investigation 2008-10-09

To determine the relationship between preoperative hypoalbuminemia and development of complications after gynecological cancer surgery, as well postoperative bowel function hospital stay.The medical records 533 patients with surgery at Konkuk University Hospital 2005 2013 were reviewed. Serum albumin level <3.5 g/dL was defined hypoalbuminemia. All perioperative within 30-days time to resumption normal diet length stay, analyzed. Regression models used assess predictors morbidity.The median...

10.5468/ogs.2015.58.5.359 article EN cc-by-nc Obstetrics & Gynecology Science 2015-01-01

Human papillomavirus can stabilize and induce hypoxia-inducible factor 1α (HIF-1α) protein, which is associated with diminished response to treatment poor prognosis for cervical cancer. Hypoxia-inducible polymorphisms (1772C>T 1790G>A) in the N-terminal transactivation domain generate significantly increased transcriptional activity have been linked outcome various malignancies.The aim of this study was analyze possible influence HIF-1α genetic on cancer susceptibility, tumor aggressiveness,...

10.1097/igc.0b013e318204f6e6 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2010-12-14
Coming Soon ...